Is Atai Beckley Inc. (ATAI) a Buy, Sell, or Hold?
Atai Beckley Inc.
NASDAQ:ATAI
$5.36 USD
-$0.31 (-5.47%)
- Volume
- 6.14M
- Average Volume
- 7.7M
- Market Capitalization
- $1.97B
- P/E Ratio
- -1.79
- Dividend Yield
- 0.00%
- Price Target
- $11.50
- Year High
- $6.75
- Year Low
- $2.59
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.02
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
34
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
12
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 798.1K
ATAI Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ATAI Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Feilding-Mellen Cosmo | director | 2025-11-25 | A-Award | 4.48 | 2025-11-26 |
| Feilding-Mellen Cosmo | director | 2025-11-25 | D-Return | 4.48 | 2025-11-26 |
| HERSHBERG ROBERT | director | 2025-11-05 | A-Award | 1.35 | 2025-11-06 |
| HERSHBERG ROBERT | director | 2025-11-05 | A-Award | 4.48 | 2025-11-06 |
| HERSHBERG ROBERT | director | 2025-11-05 | A-Award | 1.35 | 2025-11-06 |
| HERSHBERG ROBERT | director | 2025-11-05 | A-Award | 1.35 | 2025-11-06 |
| Feilding-Mellen Cosmo | director | 2025-11-05 | A-Award | 0 | 2025-11-06 |
| Feilding-Mellen Cosmo | director | 2025-11-05 | A-Award | 4.48 | 2025-11-06 |
| Feilding-Mellen Cosmo | director | 2025-11-05 | A-Award | 4.48 | 2025-11-06 |
| Braunstein Scott | director | 2025-11-04 | A-Award | 5.28 | 2025-11-06 |
| HERSHBERG ROBERT | 2025-11-05 | 0 | 2025-11-06 | ||
| Feilding-Mellen Cosmo | 2025-11-05 | 0 | 2025-11-06 | ||
| Barrett Christopher Ryan Cave | officer: See Remarks | 2025-10-01 | A-Award | 5.2 | 2025-10-03 |
| Barrett Christopher Ryan Cave | officer: See Remarks | 2025-10-01 | 0 | 2025-10-03 | |
| Barrett Christopher Ryan Cave | officer: See Remarks | 2025-10-01 | 5.68 | 2025-10-03 | |
| Barrett Christopher Ryan Cave | officer: See Remarks | 2025-10-01 | 1.18 | 2025-10-03 | |
| Barrett Christopher Ryan Cave | officer: See Remarks | 2025-10-01 | 1.84 | 2025-10-03 | |
| Barrett Christopher Ryan Cave | officer: See Remarks | 2025-10-01 | 1.5 | 2025-10-03 | |
| Barrett Christopher Ryan Cave | officer: See Remarks | 2025-10-01 | 11.71 | 2025-10-03 | |
| Barrett Christopher Ryan Cave | officer: See Remarks | 2025-10-01 | 2.44 | 2025-10-03 | |
| Barrett Christopher Ryan Cave | officer: See Remarks | 2025-10-01 | 15 | 2025-10-03 | |
| Barrett Christopher Ryan Cave | officer: See Remarks | 2025-10-01 | 5.54 | 2025-10-03 | |
| Barrett Christopher Ryan Cave | officer: See Remarks | 2025-10-01 | 2.86 | 2025-10-03 | |
| Apeiron Investment Group Ltd. | 10 percent owner | 2025-09-30 | C-Conversion | 0 | 2025-10-02 |
| Apeiron Investment Group Ltd. | 10 percent owner | 2025-09-30 | C-Conversion | 0 | 2025-10-02 |
| Apeiron Investment Group Ltd. | 10 percent owner | 2025-08-14 | P-Purchase | 2.19 | 2025-08-18 |
| Rao Srinivas | officer: See Remarks | 2025-08-13 | A-Award | 5.68 | 2025-08-15 |
| Rao Srinivas | officer: See Remarks | 2025-08-13 | A-Award | 2.5 | 2025-08-15 |
| Smiley Andrea Heslin | director | 2025-06-26 | A-Award | 2.25 | 2025-06-27 |
| Kalali Amir H | director | 2025-06-26 | A-Award | 2.25 | 2025-06-27 |
| JOHNSON SABRINA MARTUCCI | director | 2025-06-26 | A-Award | 2.25 | 2025-06-27 |
| Hoffman John Francis | director | 2025-06-26 | A-Award | 2.25 | 2025-06-27 |
| Fischer Laurent | director | 2025-06-26 | A-Award | 2.25 | 2025-06-27 |
| Braunstein Scott | director | 2025-06-26 | A-Award | 2.25 | 2025-06-27 |
| Angermayer Christian | director, 10 percent owner: | 2025-06-26 | A-Award | 2.25 | 2025-06-27 |
| Angermayer Christian | director, 10 percent owner: | 2025-06-02 | A-Award | 2.49 | 2025-06-04 |
| Hoffman John Francis | 2025-05-15 | 0 | 2025-05-23 | ||
| Kirpekar Sahil | officer: Chief Business Officer | 2025-03-21 | S-Sale | 1.35 | 2025-03-24 |
| Craig Kevin James | officer: Chief Medical Officer | 2025-03-21 | S-Sale | 1.35 | 2025-03-24 |
| Rao Srinivas | officer: See Remarks | 2025-03-21 | S-Sale | 1.35 | 2025-03-24 |
| Johnson Anne Nagengast | officer: Chief Financial Officer | 2025-03-21 | S-Sale | 1.35 | 2025-03-24 |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-03-21 | S-Sale | 1.35 | 2025-03-24 |
| Apeiron Investment Group Ltd. | 10 percent owner | 2025-03-24 | P-Purchase | 1.4 | 2025-03-24 |
| Craig Kevin James | officer: Chief Medical Officer | 2025-03-14 | M-Exempt | 0 | 2025-03-19 |
| Craig Kevin James | officer: Chief Medical Officer | 2025-03-14 | M-Exempt | 0 | 2025-03-19 |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-03-14 | M-Exempt | 0 | 2025-03-19 |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-03-14 | M-Exempt | 0 | 2025-03-19 |
| Rao Srinivas | officer: See Remarks | 2025-03-14 | M-Exempt | 0 | 2025-03-19 |
| Rao Srinivas | officer: See Remarks | 2025-03-14 | M-Exempt | 0 | 2025-03-19 |
| Kirpekar Sahil | officer: Chief Business Officer | 2025-03-14 | M-Exempt | 0 | 2025-03-19 |
| Kirpekar Sahil | officer: Chief Business Officer | 2025-03-14 | M-Exempt | 0 | 2025-03-19 |
| Johnson Anne Nagengast | officer: Chief Financial Officer | 2025-03-14 | M-Exempt | 0 | 2025-03-19 |
| Johnson Anne Nagengast | officer: Chief Financial Officer | 2025-03-14 | M-Exempt | 0 | 2025-03-19 |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-03-03 | A-Award | 1.5 | 2025-03-06 |
| Craig Kevin James | officer: Chief Medical Officer | 2025-03-03 | A-Award | 1.5 | 2025-03-06 |
| Johnson Anne Nagengast | officer: Chief Financial Officer | 2025-03-03 | A-Award | 1.5 | 2025-03-05 |
| Apeiron Investment Group Ltd. | 10 percent owner | 2025-02-14 | P-Purchase | 2.1 | 2025-02-19 |
| Rao Srinivas | officer: See Remarks | 2025-01-07 | A-Award | 1.75 | 2025-01-10 |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-01-01 | 0 | 2025-01-10 | |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-01-01 | 2.44 | 2025-01-10 | |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-01-01 | 11.71 | 2025-01-10 | |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-01-01 | 0 | 2025-01-10 | |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-01-01 | 5.68 | 2025-01-10 | |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-01-01 | 1.18 | 2025-01-10 | |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-01-01 | 1.84 | 2025-01-10 | |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-01-01 | 5.54 | 2025-01-10 | |
| Short Glenn Frank | officer: Chief Scientific Officer | 2025-01-01 | 2.86 | 2025-01-10 | |
| Craig Kevin James | officer: Chief Medical Officer | 2025-01-01 | 7.66 | 2025-01-10 | |
| Craig Kevin James | officer: Chief Medical Officer | 2025-01-01 | 0 | 2025-01-10 | |
| Craig Kevin James | officer: Chief Medical Officer | 2025-01-01 | 1.18 | 2025-01-10 | |
| Craig Kevin James | officer: Chief Medical Officer | 2025-01-01 | 5.54 | 2025-01-10 | |
| Craig Kevin James | officer: Chief Medical Officer | 2025-01-01 | 2.86 | 2025-01-10 | |
| Craig Kevin James | officer: Chief Medical Officer | 2025-01-01 | 1.84 | 2025-01-10 | |
| Kochendoerfer Gerd | officer: Chief Operating Officer | 2025-01-02 | A-Award | 1.6 | 2025-01-03 |
| Kochendoerfer Gerd | 2024-12-03 | 0 | 2024-12-13 | ||
| Angermayer Christian | director, 10 percent owner: | 2024-10-04 | A-Award | 5.68 | 2024-10-04 |
| Angermayer Christian | director, 10 percent owner: | 2024-10-04 | D-Return | 5.68 | 2024-10-04 |
| Johnson Anne Nagengast | officer: Chief Financial Officer | 2024-10-04 | A-Award | 5.68 | 2024-10-04 |
| Johnson Anne Nagengast | officer: Chief Financial Officer | 2024-10-04 | A-Award | 11.71 | 2024-10-04 |
| Johnson Anne Nagengast | officer: Chief Financial Officer | 2024-10-04 | D-Return | 11.71 | 2024-10-04 |
| Johnson Anne Nagengast | officer: Chief Financial Officer | 2024-10-04 | D-Return | 5.68 | 2024-10-04 |
| Rao Srinivas | officer: See Remarks | 2024-10-04 | A-Award | 2.44 | 2024-10-04 |
| Rao Srinivas | officer: See Remarks | 2024-10-04 | A-Award | 2.44 | 2024-10-04 |
| Rao Srinivas | officer: See Remarks | 2024-10-04 | A-Award | 11.71 | 2024-10-04 |
| Rao Srinivas | officer: See Remarks | 2024-10-04 | D-Return | 2.44 | 2024-10-04 |
| Rao Srinivas | officer: See Remarks | 2024-10-04 | D-Return | 11.71 | 2024-10-04 |
| Brand Florian | officer: See Remarks | 2024-10-04 | A-Award | 0.37 | 2024-10-04 |
| Brand Florian | officer: See Remarks | 2024-10-04 | A-Award | 5.68 | 2024-10-04 |
| Brand Florian | officer: See Remarks | 2024-10-04 | A-Award | 11.71 | 2024-10-04 |
| Brand Florian | officer: See Remarks | 2024-10-04 | D-Return | 11.71 | 2024-10-04 |
| Brand Florian | officer: See Remarks | 2024-10-04 | D-Return | 0.37 | 2024-10-04 |
| Brand Florian | officer: See Remarks | 2024-10-04 | D-Return | 5.68 | 2024-10-04 |
| Auerbach Michael | director | 2024-06-13 | A-Award | 1.34 | 2024-06-14 |
| Angermayer Christian | director, 10 percent owner: | 2024-06-13 | A-Award | 1.34 | 2024-06-14 |
| Braunstein Scott | director | 2024-06-13 | A-Award | 1.34 | 2024-06-14 |
| Smiley Andrea Heslin | director | 2024-06-13 | A-Award | 1.34 | 2024-06-14 |
| Fischer Laurent | director | 2024-06-13 | A-Award | 1.34 | 2024-06-14 |
| Kalali Amir H | director | 2024-06-13 | A-Award | 1.34 | 2024-06-14 |
| JOHNSON SABRINA MARTUCCI | director | 2024-06-13 | A-Award | 1.34 | 2024-06-14 |
| Braunstein Scott | 2024-05-31 | 0 | 2024-06-04 |